SEC Form 4 · accession 0001179110-16-028198
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henri A Termeer
Director
Period of report
Aug 1, 2016
Accepted (ET)
Aug 3, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Aug 1, 2016 | M | 8,000 | $13.21 | A | 325,778 | D | |
| Common Stock, $0.01 par valueF4,F5 | Aug 1, 2016 | S | 3,744 | $118.7022 | D | 322,034 | D | |
| Common Stock, $0.01 par value | Aug 1, 2016 | M | 8,000 | $12.69 | A | 330,034 | D | |
| Common Stock, $0.01 par valueF4,F5 | Aug 1, 2016 | S | 3,991 | $118.7022 | D | 326,043 | D | |
| Common Stock, $0.01 par value | Aug 1, 2016 | M | 12,000 | $18.63 | A | 338,043 | D | |
| Common Stock, $0.01 par valueF4,F5 | Aug 1, 2016 | S | 6,409 | $118.7022 | D | 331,634 | D | |
| Common Stock, $0.01 par value | Aug 1, 2016 | M | 12,000 | $7.67 | A | 343,634 | D | |
| Common Stock, $0.01 par valueF4,F5 | Aug 1, 2016 | S | 5,796 | $118.7022 | D | 337,838 | D | |
| Common Stock, $0.01 par value | Aug 1, 2016 | M | 12,000 | $9.99 | A | 349,838 | D | |
| Common Stock, $0.01 par valueF4,F5 | Aug 1, 2016 | S | 5,926 | $118.7022 | D | 343,912 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $13.21 | Aug 1, 2016 | M | 8,000 | D | Aug 8, 2007 | Aug 9, 2016 | Common Stock | 8,000 | 0 | D |
| Stock option (right to buy)F2,F1 | $12.69 | Aug 1, 2016 | M | 8,000 | D | Aug 13, 2008 | Aug 8, 2017 | Common Stock | 8,000 | 0 | D |
| Stock Option (right to buy)F3,F1 | $18.63 | Aug 1, 2016 | M | 12,000 | D | Aug 12, 2009 | Aug 13, 2018 | Common Stock | 12,000 | 0 | D |
| Stock Option (right to buy)F3,F1 | $7.67 | Aug 1, 2016 | M | 12,000 | D | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 0 | D |
| Stock Options (right to buy)F3,F1 | $9.99 | Aug 1, 2016 | M | 12,000 | D | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1This option becomes exercisable in full on the date set forth in Table II, Column 6.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F3Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4Transaction represents sale of shares with proceeds delivered to the issuer for payment of exercise price of options under the issuer's employee stock option plan and the related tax withholding.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $118.1200 and $119.0300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.